Coherus Oncology, Inc. (CHRS): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$286.0K
Year ended 2023-12-31
-65.9%
3-year compound annual growth
-18.4%
5-year compound annual growth
-2.6%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $286.0K | -86.0% | 2024-03-15, From 2023-01-01 |
| 2022-12-31 | $2.04M | +58.2% | 2024-03-15, From 2022-01-01 |
| 2021-12-31 | $1.29M | -82.2% | 2024-03-15, From 2021-01-01 |
| 2020-12-31 | $7.23M | +296.9% | 2023-03-06, From 2020-01-01 |
| 2019-12-31 | $1.82M | +130.9% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $789.0K | -82.7% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $4.57M | -29.8% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $6.51M | +5.7% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $6.16M | +116.4% | 2018-03-08, From 2015-01-01 |
| 2014-12-31 | $2.85M | +663.8% | 2017-03-14, From 2014-01-01 |
| 2013-12-31 | $373.0K | -79.1% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $1.78M | n/a | 2015-03-23, From 2012-01-01 |